Data / Form D filings / ACADIA PHARMACEUTICALS INC
ACADIA PHARMACEUTICALS INC: Form D filings
ACADIA PHARMACEUTICALS INC, a pharmaceuticals company in San Diego, CA, filed 2 Form D notices with the SEC between 2011 and 2013. The latest, on January 2, 2013, reports $86.4 million sold of a $86.4 million offering to 29 investors.
Find out what ACADIA PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3911 SORRENTO VALLEY BLVD, San Diego, CA, 92121
- Phone
- (858) 558-2871
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1070494
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 2, 2013 | New notice | $86,385,000 | $86,385,000 | $0 | 29 | Dec 17, 2012 | sec.gov |
| Jan 24, 2011 | New notice | $21,069,109 | $21,069,109 | $0 | 5 | Jan 12, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MARY ANN T GRAY | Director | |
| ULI HACKSELL | Executive Officer, Director | |
| ROGER G MILLS | Executive Officer | |
| LAURA A BREGE | Director | |
| WILLIAM M WELLS | Director | |
| THOMAS H AASEN | Executive Officer | |
| LESTER J KAPLAN | Director | |
| LESLIE L IVERSEN | Director | |
| MICHAEL T BORER | Director | |
| TORSTEN T RASMUSSEN | Director | |
| GLENN F BAITY | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 31, 2012 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ACADIA PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.